| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $549.8M | — | +0.3% |
| R&D Expense | $465K | — | -0.4% |
| SG&A Expense | $91.5M | — | +2.6% |
| Operating Income | $793K | — | -97.3% |
| Interest Expense | $27.8M | — | +4.7% |
| Pre-tax Income | -$32.8M | — | -602.0% |
| Income Tax | -$24.4M | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $105.7M | +2.0% | +3.1% |
| Accounts Receivable | $285.5M | +6.8% | — |
| Inventory | $173.3M | -4.0% | — |
| Current Assets | $722.1M | +0.2% | — |
| Total Assets | $2.70B | -0.2% | — |
| Current Liabilities | $640.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $21.5M | — | +226.3% |
| Capital Expenditures | $33.7M | — | +56.0% |
| Investing Cash Flow | -$30.7M | — | -66.2% |
| Financing Cash Flow | $8.1M | — | -69.2% |
| Free Cash Flow | -$12.2M | — | +18.9% |
| -1318.7% |
| Net Income | -$10.7M | — | -18.3% |
| EPS (Basic) | -$0.13 | — | -18.2% |
| EPS (Diluted) | -$0.13 | — | -18.2% |
| +1.1% |
| — |
| Long-term Debt | $1.56B | +1.7% | — |
| Total Liabilities | $2.43B | +0.7% | — |
| Stockholders' Equity | $233.2M | -8.6% | -46.1% |